LCID
Lucid Group, Inc.
LCID has a slight edge over WEN overall, supported by stronger modeled upside and stronger fundamentals.
WEN
The Wendy's Company
WEN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
WEN's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
WEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $5.76 | -30% |
| Current | 16x | $8.18 | — |
| Fair | 23x | $11.48 | +40% |
| Expensive | 39x | $19.70 | +141% |
Historical ranges are pointers, not guarantees.
WEN's PE is in its cheap range at 16x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
WEN Forward outlook
There aren't enough analyst estimates for WEN to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
WEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.51 | -46% |
| Q2 2026 | $0.66 | -31% |
| Q1 2026 | $0.78 | -17% |
| Q4 2025 | $0.85 | -11% |
| Q3 2025 | $0.94 | 0% |
| Q2 2025 | $0.96 | -1% |
| Q1 2025 | $0.94 | -4.1% |
| Q4 2024 | $0.95 | -2.1% |
WEN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over WEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
WEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $547M | -0.5% |
| Q2 2026 | $570.6M | +1.7% |
| Q1 2026 | $540.6M | +3.3% |
| Q4 2025 | $543M | -5.5% |
| Q3 2025 | $549.5M | -3% |
| Q2 2025 | $560.9M | -1.7% |
| Q1 2025 | $523.5M | -2.1% |
| Q4 2024 | $574.3M | +6.2% |
WEN's revenue grew through 2022 and has held roughly level since: $547M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -6.6 points |
| Q2 2026 | 14% | -4.7 points |
| Q1 2026 | 12% | -3.9 points |
| Q4 2025 | 12% | -4.9 points |
| Q3 2025 | 17% | 0 points |
| Q2 2025 | 19% | +1.1 points |
| Q1 2025 | 16% | +0.7 points |
| Q4 2024 | 17% | +0.7 points |
WEN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
WEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.7M | -41% |
| Q2 2026 | $81M | +107% |
| Q1 2026 | $47.5M | -30% |
| Q4 2025 | $31.4M | +18% |
| Q3 2025 | $104.3M | -15% |
| Q2 2025 | $39.2M | +38% |
| Q1 2025 | $67.7M | -18% |
| Q4 2024 | $26.6M | -43% |
WEN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
WEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +589K shares |
| 1 year | +0.3% | +548K shares |
| 3 years | -8.9% | -18.8M shares |
| 5 years | -15% | -33.3M shares |
| Available history | -18% | -43.3M shares |
WEN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $14.3M |
| Q2 2025 | $63.7M |
| Q1 2025 | $122.8M |
| Q4 2024 | $17.3M |
WEN spent $2M buying back its own shares over the past year, down 99% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 5.0x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
WEN's net debt is about 5.6 years of its operating earnings (EBITDA), up from 4.7 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
WEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 59.6 | Neutral |
WEN's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
WEN PE vs Consumer Cyclical Sector
| Metric | WEN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 25 | 47 | 22 pts below |
WEN is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
WEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.92 | 18% above |
| 20 week MA | $7.48 | 9.4% above |
| 50 week MA | $7.56 | 8.2% above |
| 100 week MA | $9.77 | 16% below |
| 200 week MA | $14.7 | 44% below |
WEN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
WEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.2 | $22.5 | +1.3% |
| 2021 | $22.5 | $23.3 | +3.9% |
| 2022 | $23.3 | $23.1 | -0.9% |
| 2023 | $23.1 | $19.5 | -16% |
| 2024 | $19.5 | $16.5 | -15% |
| 2025 | $16.5 | $8.35 | -49% |
| 2026 YTD | $8.35 | $8.18 | -2% |
WEN has the edge over LCID on returns for 2026, with the stronger performance.